Statistical mediation of the relationships between chronological age and lipoproteins by nonessential amino acids in healthy men.
Aging
Glutamate
Lipoproteins
Metabolomics
NMR
Journal
Computational and structural biotechnology journal
ISSN: 2001-0370
Titre abrégé: Comput Struct Biotechnol J
Pays: Netherlands
ID NLM: 101585369
Informations de publication
Date de publication:
2021
2021
Historique:
received:
16
07
2021
revised:
26
10
2021
accepted:
14
11
2021
entrez:
13
12
2021
pubmed:
14
12
2021
medline:
14
12
2021
Statut:
epublish
Résumé
Aging is a major risk factor for metabolic impairment that may lead to age-related diseases such as cardiovascular disease. Different mechanisms that may explain the interplay between aging and lipoproteins, and between aging and low-molecular-weight metabolites (LMWMs), in the metabolic dysregulation associated with age-related diseases have been described separately. Here, we statistically evaluated the possible mediation effects of LMWMs on the relationships between chronological age and lipoprotein concentrations in healthy men ranging from 19 to 75 years of age. Relative and absolute concentrations of LMWMs and lipoproteins, respectively, were assessed by nuclear magnetic resonance (NMR) spectroscopy. Multivariate linear regression and mediation analysis were conducted to explore the associations between age, lipoproteins and LMWMs. The statistical significance of the identified mediation effects was evaluated using the bootstrapping technique, and the identified mediation effects were validated on a publicly available dataset. Chronological age was statistically associated with five lipoprotein classes and subclasses. The mediation analysis showed that serine mediated 24.1% (95% CI: 22.9 - 24.7) of the effect of age on LDL-P, and glutamate mediated 17.9% (95% CI: 17.6 - 18.5) of the effect of age on large LDL-P. In the publicly available data, glutamate mediated the relationship between age and an NMR-derived surrogate of cholesterol. Our results suggest that the age-related increase in LDL particles may be mediated by a decrease in the nonessential amino acid glutamate. Future studies may contribute to a better understanding of the potential biological role of glutamate and LDL particles in aging mechanisms and age-related diseases.
Identifiants
pubmed: 34900130
doi: 10.1016/j.csbj.2021.11.022
pii: S2001-0370(21)00487-6
pmc: PMC8632714
doi:
Types de publication
Journal Article
Langues
eng
Pagination
6169-6178Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Res Pharm Sci. 2012 Oct;7(4):209-15
pubmed: 23248671
Int J Epidemiol. 2013 Aug;42(4):1111-9
pubmed: 23838602
Cell. 2014 Nov 6;159(4):709-13
pubmed: 25417146
Science. 1993 Oct 29;262(5134):689-95
pubmed: 7901908
Nutr Metab Cardiovasc Dis. 2001 Aug;11(4 Suppl):70-3
pubmed: 11894758
Mech Ageing Dev. 2015 Nov;151:101-13
pubmed: 25804383
PLoS Genet. 2014 Feb 06;10(2):e1004113
pubmed: 24516402
Nucleic Acids Res. 2018 Jan 4;46(D1):D608-D617
pubmed: 29140435
Pharmacogenomics. 2008 Apr;9(4):383-97
pubmed: 18384253
Curr Opin Lipidol. 2011 Jun;22(3):176-85
pubmed: 21537175
Clin Lab Med. 2006 Dec;26(4):847-70
pubmed: 17110242
Anal Methods. 2020 May 14;12(18):2355-2362
pubmed: 32930261
Trends Mol Med. 2011 Oct;17(10):594-603
pubmed: 21839683
Metabolomics. 2016;12:51
pubmed: 26900388
PLoS One. 2017 May 18;12(5):e0177749
pubmed: 28542375
Clin Interv Aging. 2018 Apr 26;13:757-772
pubmed: 29731617
Cell Metab. 2012 May 2;15(5):606-14
pubmed: 22560213
Arterioscler Thromb Vasc Biol. 2003 Oct 1;23(10):1881-8
pubmed: 12920049
Aging Cell. 2012 Dec;11(6):960-7
pubmed: 22834969
Curr Opin Lipidol. 2010 Aug;21(4):312-8
pubmed: 20581677
Front Genet. 2012 Aug 23;3:148
pubmed: 22936945
J Clin Lipidol. 2016 Jan-Feb;10(1):124-33
pubmed: 26892129
J Am Heart Assoc. 2016 Sep 15;5(9):
pubmed: 27633391
PLoS Med. 2006 Dec;3(12):e495
pubmed: 17194192
Anal Chem. 2015 Jan 6;87(1):706-15
pubmed: 25485990
Am J Clin Nutr. 2005 Aug;82(2):342-9
pubmed: 16087977
J Clin Lipidol. 2015 Nov-Dec;9(6):824-831.e1
pubmed: 26687704
J Genet Genomics. 2020 Feb 20;47(2):69-83
pubmed: 32178981
J Physiol. 2016 Apr 15;594(8):2061-73
pubmed: 26391109
Metabolites. 2019 Mar 05;9(3):
pubmed: 30841604
Proteomics. 2020 Mar;20(5-6):e1800407
pubmed: 32068959
Clin Chem. 2004 Jul;50(7):1189-200
pubmed: 15107310
Physiol Rev. 1998 Apr;78(2):547-81
pubmed: 9562038
Anal Chem. 2014 Jan 21;86(2):1160-9
pubmed: 24354303
Mass Spectrom Rev. 2007 Jan-Feb;26(1):51-78
pubmed: 16921475
Aging (Albany NY). 2019 Feb 24;11(4):1262-1282
pubmed: 30799310
PLoS One. 2013;8(3):e56564
pubmed: 23483888
Am Heart J. 2014 Jul;168(1):45-52.e7
pubmed: 24952859
Lipids Health Dis. 2021 Apr 3;20(1):30
pubmed: 33812378
J Gerontol A Biol Sci Med Sci. 2016 May;71(5):578-85
pubmed: 26019184
Lipids Health Dis. 2018 Jan 5;17(1):6
pubmed: 29304826
Metabolites. 2019 Jun 27;9(7):
pubmed: 31252628
JAMA. 1988 Oct 7;260(13):1917-21
pubmed: 3418853
Acta Diabetol. 2012 Jun;49(3):167-83
pubmed: 22218826
Methods Mol Biol. 2020;2112:187-218
pubmed: 32006287